ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $21,479,000 | +22.3% | 124,807 | -10.8% | 0.04% | +28.6% |
Q2 2021 | $17,562,000 | +2.7% | 139,948 | +11.0% | 0.04% | -5.4% |
Q1 2021 | $17,100,000 | +35.0% | 126,102 | +27.4% | 0.04% | +27.6% |
Q4 2020 | $12,665,000 | -5.4% | 98,987 | -16.8% | 0.03% | -14.7% |
Q3 2020 | $13,394,000 | +40.9% | 119,024 | +19.3% | 0.03% | +30.8% |
Q2 2020 | $9,507,000 | +19.0% | 99,779 | +12.3% | 0.03% | -3.7% |
Q1 2020 | $7,987,000 | +55.1% | 88,889 | -8.5% | 0.03% | +92.9% |
Q4 2019 | $5,151,000 | – | 97,170 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |